The Tahya Misr Fund signed a cooperation agreement with Saudi Arabia’s CAD Pharma for a planned EGP 1 bn cancer medication factory, Chairman of the Tahya Misr Fund Mohamed El Ashmawy tells Al Borsa. The agreement will see the two sides study the market’s needs before moving ahead with constructing the factory. Ashmawy says the first EGP 300 mn production line is expected to be complete before the end of 2018.

Tags: